DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

TruAlt Bioenergy Limited — Sale or disposal-XBRL

NSE 3 hrs ago·4 Aug 2026, 7:34 am

Trualt Bioenergy

TruAlt Bioenergy Limited has informed stock exchanges that it is considering the sale or disposal of one or more of its units, divisions, or subsidiaries. This strategic move suggests the company is evaluating its portfolio to focus on core operations or improve its financial structure.

For investors, this development is significant as it could lead to a change in the company's earnings profile or asset base. While a sale might unlock value, it could also signal a shift in the company's long-term strategy. Investors should monitor the outcome to understand the impact on TruAlt's future growth prospects.

What to watch next includes the specific assets being considered for disposal and the timeline for any potential transaction. Market participants will also be keen to see how the company plans to use any proceeds from the sale and whether this move strengthens its operational focus.